These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 4723589)

  • 21. Pharmacokinetics of theophylline in children with asthma.
    Ellis EF; Koysooko R; Levy G
    Pediatrics; 1976 Oct; 58(4):542-7. PubMed ID: 972795
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Comparison of bronchodilating and metabolic effects of intravenous aminophylline and subcutaneous epinephrine individually and in combination in patients with bronchial asthma].
    Kihara N; Makino S
    Arerugi; 1982; 31(7):390-400. PubMed ID: 6295342
    [No Abstract]   [Full Text] [Related]  

  • 23. Serum concentrations of theophylline in children following the administration of doses generally recommended: new dosage regimen required.
    Selvig K; Holmen TL; Aas K; Rugstad HE; Bjerve KS
    Acta Paediatr Scand; 1979 May; 68(3):435-9. PubMed ID: 443044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theophylline concentration following equal doses of intravenous aminophylline and oral theophylline in preterm infants.
    al-Omran A; al-Alaiyan S
    Am J Perinatol; 1997 Mar; 14(3):147-9. PubMed ID: 9259917
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The design of oral sustained-release theophylline dosing after conversion from intravenous to oral therapy.
    Yamazaki M; Fukutomi O; Kondo N; Kato Z; Nakashima Y; Shinoda S; Agata H; Kondo T; Imaeda N; Orii T
    Int J Clin Pharmacol Ther; 1994 Nov; 32(11):625-31. PubMed ID: 7874380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of pulmonary function during periodic intravenous bolus aminophylline therapy.
    Koup JR; Brodsky B
    Ther Drug Monit; 1979; 1(1):85-91. PubMed ID: 553333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The beginning of water-soluble corticosteroid action in an asthma attack].
    Reinert M
    MMW Munch Med Wochenschr; 1976 Mar; 118(11):335-6. PubMed ID: 817159
    [No Abstract]   [Full Text] [Related]  

  • 28. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
    Branica S; Vrabec B; Francetić I; Bakran I
    Lijec Vjesn; 1989; 111(9-10):341-3. PubMed ID: 2633012
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma theophylline level and effect on lung function after oral and rectal administration of aminophylline.
    Lamont H; Moerman E; Bogaert M; Van Der Straeten M; Pauwels R
    Eur J Clin Pharmacol; 1979 Jul; 15(6):401-6. PubMed ID: 499288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A spectrophotometric micromethod for the study of theophylline pharmacokinetics in children with bronchial asthma].
    Gavalov SM; Ivanova TA; Kaznacheeva LF; Smirnova LP; Slabuko PA
    Farmakol Toksikol; 1986; 49(5):27-9. PubMed ID: 3770169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theophylline concentrations in asthmatic patients after administration of aminophylline.
    Kordash TR; Van Dellen RG; McCall JT
    JAMA; 1977 Jul; 238(2):139-41. PubMed ID: 577283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Evaluation of Euphylline-retard based on the measurement of theophylline concentration in the blood serum and spirometric parameters].
    Pietruszewska E; Droszcz W; Wrońska J; Kowalski J
    Pneumonol Pol; 1981 Nov; 49(11):783-9. PubMed ID: 7342049
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of two calcium antagonists, verapamil and gallopamil (D-600), in exercise-induced asthma.
    Patel KR; Tullett WM
    Eur J Respir Dis; 1985 Oct; 67(4):269-71. PubMed ID: 4076366
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of single dose intravenous aminophylline in asthma.
    Pyun BY; Odajima Y; Kishida M; Obata T; Nagakura T; Iikura Y
    Acta Paediatr Jpn; 1987 Dec; 29(6):827-32. PubMed ID: 3144147
    [No Abstract]   [Full Text] [Related]  

  • 35. [Theophylline concentration in the blood of children with persistently recurring bronchial asthma].
    Gusel' VA; Zisel'son AD; Verbov VN; Gorshkova IuG
    Farmakol Toksikol; 1986; 49(5):29-31. PubMed ID: 3770170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetic/pharmacodynamic modeling of theophylline in patients with different degrees of airway obstruction.
    Flores-Murrieta FJ; Mercado DE; Rodríguez-Silverio J; Chapela R
    Proc West Pharmacol Soc; 1999; 42():3-4. PubMed ID: 10697671
    [No Abstract]   [Full Text] [Related]  

  • 37. [Relation of dose, serum concentration and side effects in intravenous aminophylline therapy].
    Katz G; Kewitz G; Vozeh S; Follath F
    Schweiz Med Wochenschr; 1981 Dec; 111(52):2054-6. PubMed ID: 7330656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adequacy of recommended aminophylline loading doses in children.
    Maxwell-Rubin M; Paap CM; Godley PJ
    Am J Hosp Pharm; 1994 Jul; 51(13):1667-71. PubMed ID: 7942891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intravenous maintenance aminophylline dosage in patients with asthma on regular oral theophylline.
    Chang KC; Chai H; Miles-Lawrence R; Bell TD; Pinney CT
    Ann Allergy; 1982 Dec; 49(6):315-7. PubMed ID: 7149347
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dangers of compound drugs and intravenous aminophylline.
    Thompson PJ; Hay JG
    Lancet; 1982 Nov; 2(8309):1228. PubMed ID: 6128542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.